Hormone responses to citalopram in abstinent alcohol dependent subjects

Alcoholism: Clinical and Experimental Research

Volumn 26, Issue 11, 2002, Pages 1625-1631

  Gotjen, Deidre ^a   Szabo, Zsolt ^a   Lee, Shing ^a   Wand, Gary ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenocorticotropin; Citalopram; Cortisol; Neuroendocrine; Polymorphism; Prolactin; Serotonin Transporter

Indexed keywords

CITALOPRAM; CORTICOTROPIN; HYDROCORTISONE; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEROTONINERGIC SYSTEM;

EID: 0036861783     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2002.tb02464.x     Document Type: Article

References (41)

1. Angelone SM, Bellini L, Di Bella D, Catalano M (1998) Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics. Alcohol Alcohol 33:151-156.
2. Anthenelli RM, Maxwell RA (2000) Cigarette smoking decreases the prolactin response to serotonergic stimulation in sub-groups of alcoholics and controls. Alcohol Clin Exp Res 24(7):987-995.
3. Anthenelli RM, Maxwell RA, Geracioti TD Jr, Hauger R (2001) Stress hormone dysregulation at rest and after serotonergic stimulation among alcohol-dependent men with extended abstinence and controls. Alcohol Clin Exp Res 25:692-703.
4. Anton RF, Dominick C, Bigelo M, Westby C; CDTect Research Group (2001) Comparison of Bio-rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gammaglutamyltransferase. Clin Chem 47:1679-1775.
5. Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ (2001) Low dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology 155:323-326.
6. Balldin J, Berggren U, Engel J, Eriksson M (1994) Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking. Alcohol Clin Exp Res 18:822-825.
7. Ballenger JC, Goodwin FK, Major LF, Brown GL (1979) Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 36:224-227.
8. Berggren U, Eriksson M, Fahlke C, Balldin J (2002) Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission. Drug Alcohol Depend 65:159-165.
9. Borg S, Kyande H, Liljeberg P, Mossberg D, Valverius P (1985) 5-hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol 2:415-418.
10. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI Jr, Reich T, Schmidt I, Schuckit MA (1994) A new semi-structured psychiatric interview for use in genetic linkage studies: A report on the reliability of the SSAGA. J Stud Alcohol 55:149-158.
11. Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C (1997) Hormonal, psychological and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics. Alcohol Clin Exp Res 21:220-226.
12. Costa PT, Fagan PJ, Piedmont RL, Ponticas Y, Wise TN (1992) The five-factor model of personality and sexual functioning in outpatient men and women. Psychiatr Med 10:199-215.
13. Costa PT, McCrae RR (1997) Stability and change in personality assessment: The revised NEO Personality Inventory in the year 2000. J Pers Assess 68:86-94.
14. DSM-IV; American Psychiatric Association, Washington, DC, 1997.
15. Fisher LA, Elias JW, Ritz K (1998) Predicting relapse to substance abuse as a function of personality dimensions. Alcohol Clin Exp Res 22:1041-1047.
16. George DT, Benkelfat C, Rawlings RR, Eckardt MJ, Phillips MJ, Nutt DJ, Wynne D, Murphy DL, Linnoila M (1997) Behavioral and Neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. Am J Psychiatry 154:81-87.
17. Handelsman L, Holloway K, Kahn RS, Sturiano C, Rinaldi PJ, Bernstein DP, Siever L, Gabriel S, Cooper TB (1996) Hostility is associated with a low prolactin response to meta-chlorophenylpiperazine in abstinent alcoholics. Alcohol Clin Exp Res 20:824-829.
18. Hartka E, Johnstone B, Leino EV, Motoyoshi M, Temple MT, Fillmore KM (1991) A meta-analysis of depressive symptomatology and alcohol consumption over time. Br J Addict 86:1283-1298.
19. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR (2000) A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47:643-649.
20. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M (1998) Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155:1544-1549.
21. Kapitany T, Schindl M, Schindler SD, Hesselmann B, Fureder T, Barnas C, Siegart W, Kasper S (1999) The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Res 88:75-88.
22. Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS (1996) Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry 153:83-92.
23. Lee MA, Meltzer HY (1991) Neuroendocrine responses to serotonergic agents in alcoholics. Biol Psychiatry 30:1017-1030.
24. LeMarquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse and dependence: Clinical evidence. Biol Psychiatry 36: 326-337.
25. McBride WJ, Chernet E, Russell RN, Chamberlain JK, Lumeng L, Li TK (1997) Regional CNS densities of serotonin and dopamine receptors in high alcohol-drinking (HAD) and low alcohol-drinking (LAD) rats. Alcohol 14:603-609.
26. McBride WJ, Li TK (1998) Animal models of alcoholism: Neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12:339-369.
27. McKinzie DL, Eha R, Cox R, Stewart RB, Dyr W, Murphy JM, McBride WJ, Lumeng L, Li TK (1998) Serotonin 3 receptor antagonism of alcohol intake: Effects of drinking conditions. Alcohol 15:291-298.
28. McKinzie DL, McBride WJ, Murphy JM, Lumeng L, Li TK (2000) Effects of MDL 72222, a serotonin 3 antagonist, on operant responding for ethanol by alcohol-preferring P rats. Alcohol Clin Exp Res 24:1500-1504.
29. Naranjo CA, Knoke D (2001) The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. J Clin Psychol 62:18-25.
30. Naranjo CA, Knoke DM, Bremmer KE (2000) Variations in response to citalopram in men and women with alcohol dependence. J Psychiatr Neurosci 25:269-275.
31. Pettinati HM (2001) The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes. J Clin Psychol 62:26-31.
32. Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A (2001) Double-blind clinical trial of sertraline treatment for alcohol dependence. J Clin Psychopharmacol 21:143-153.
33. Quirk SW, McCormick RA (1998) Personality subtypes, coping styles, symptom correlates, and substances of choice among a cohort of substance abusers. Assessment 5:157-169.
34. Rice JP, Reich T, Bucholz KK, Neuman RJ, Fishman R, Rochberg N, Hesselbrock VM, Nurnberger JI Jr, Schuckit MA, Begleiter H (1995) Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res 19:1018-1023.
35. Rothman RB, Baumann MH (2002) Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav 71:825-836.
36. Wand GS, Dobs A (1991) Characterization of the pituitary-adrenal axis in actively drinking, non-depressed alcoholics. J Clin Endocrinol Metab 72:1290.
37. Wand GS, Froehlich J (1991) Alternations in hypothalamo-hypophysial function by ethanol, Neuroendocrine Perspectives (Muller E, MacLeod RM eds), vol 9, pp 45-126. Springer-Verlag, New York.
38. Wand GS (1993) Ethanol, the hypothalamic-pituitary-adrenal axis and hormonal tolerance. NIAAA Research Monograph 3:27-45.
39. Wand GS (2000) Hypothalamic-pituitary-adrenal axis: Changes and risk for alcoholism. Review of NIAAA's Neuroscience and Behavioral Research Portfolio. NIAAA Research Monograph No. 34 (Noronha A, Eckardt M, Warren K eds), pp 297-415.
40. Wand GS, Mangold D, Ali M (1999) Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men. J Clin Endocrine Metab 84:64-68.
41. Wand GS, Mangold D, El Deiry S, McCaul ME, Hoover D (1998) Family history of alcoholism and hypothalamic opioidergic activity. Arch Gen Psychol 55:1114-1119.